PARADIGM BIOPHARMACEUTICALS LIMITED..

3.39%

30.5¢

Market Cap $121.2M

Healthcare Biotechnology

Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug... Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug development company focused on delivering new therapies to address unmet medical needs.More

Corporate Spotlight

Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug development company focused on delivering new therapies to address unmet medical needs.
View the full Corporate Spotlight

PAR - close to a cure for osteoarthritis?

Latest Threads

Tag

Subject

PAR

Competition???

2 3

00:37

146

57K

00:37

Last post Mangoman605

146

57K

PAR

research reports and media

77 78 79

21/08/25

4.7K

2.2M

21/08/25

Last post ademski79

4.7K

2.2M

PAR

Chart

81 82 83

20/08/25

4.9K

4.2M

20/08/25

Last post wazza239

4.9K

4.2M

PAR

PAR - Broker Data

15/08/25

109

31K

15/08/25

Last post MixedBag

109

31K

PAR

The Probability of Success

11/08/25

15K

11/08/25

Last post Mozzarc

15K

PAR

Ann: Investor Webinar Presentation

05/08/25

24K

05/08/25

Last post Ollie3039

24K

PAR

Ann: Loyalty and Piggyback Options Program

9 10 11

01/08/25

607

214K

01/08/25

Last post R-7

607

214K

PAR

Sharewise Presentation 22/7/24

2 3

01/08/25

146

53K

01/08/25

Last post Denial

146

53K

See All Discussions

Timeline

Investor Webinar Presentation
31 Jul 08:56	Share

June 2025 Quarterly Activities Report & Appendix 4C
29 Jul 09:26	Share

Paradigm Investor Webinar
24 Jul 09:22	Share

Application for quotation of securities - PAR
22 Jul 14:57	Share

Notice under Section 708A
07 Jul 16:03	Share

Notification regarding unquoted securities - PAR
07 Jul 14:49	Share

Notice under Section 708A
02 Jul 12:59	Share

Application for quotation of securities - PAR
02 Jul 12:52	Share

Proposed issue of securities - PAR
01 Jul 08:54	Share

Proposed issue of securities - PAR
01 Jul 08:39	Share

Paradigm Secures US$27M to Advance Phase 3 OA Trial
01 Jul 08:31	Share

US Sites Activated and Patients Consented
30 Jun 14:07	Share

Paradigm Strengthens OA Pipeline with Strategic Acquisition
26 Jun 08:27	Share

Phase 3 Knee OA Trial Begins, Site Live, Patient Consented
03 Jun 08:41	Share

Results of Meeting
29 May 17:10	Share

PAR Receives US Ethics Approval for Phase 3
15 May 08:24	Share

Notice of General Meeting/Proxy Form
29 Apr 16:57	Share

March 2025 Quarterly Activities Report & Appendix 4C
29 Apr 13:51	Share

Paradigm to present at NWR Healthcare Conference
18 Mar 15:02	Share

Application for quotation of securities - PAR
14 Mar 15:05	Share

S&P DJI Announces March 2025 Quarterly Rebalance
07 Mar 17:01	Share

Appendix 4D and Half Year Report
28 Feb 08:12	Share

Paradigm Secures Ethics Approval for Phase 3 Trial
24 Feb 08:06	Share

Change of Director's Interest Notice
14 Feb 14:41	Share

Change of Director's Interest Notice
14 Feb 14:41	Share

Listing of Options - Top 20 Holders and Distribution Reports
11 Feb 09:10	Share

Application for quotation of securities - PAR
11 Feb 09:02	Share

Proposed issue of securities - PAR
03 Feb 08:28	Share

Cancel - Proposed issue of securities - PAR
03 Feb 08:28	Share

Proposed issue of securities - PAR
31 Jan 16:29	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 30.5¢		Change 0.010(3.39%)		Mkt cap ! $121.2M

Open	High	Low	Value	Volume
29.5¢	30.8¢	29.5¢	$110.4K	368.5K

Buyers (Bids)

No.	Vol.	Price($)
4	118440	30.0¢

Sellers (Offers)

Price($)	Vol.	No.
31.0¢	25841	2

View Market Depth

No.	Vol.	Price($)
4	118440	0.300
15	383247	0.295
18	402708	0.290
6	53147	0.285
9	253912	0.280

Price($)	Vol.	No.
0.310	25841	2
0.325	93650	4
0.330	84717	6
0.335	35982	4
0.340	277110	4

Last trade - 16.10pm 21/08/2025 (20 minute delay)

PAR (ASX) Chart

PARADIGM BIOPHARMACEUTICALS LIMITED..

Corporate Spotlight

Latest Threads

Timeline

Featured News

Latest Videos

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

27 Jun 2025 12:33 (AEST)

This stock could have something close to a cure for osteoarthritis. Don’t let it hide under your nose

21 May 2025 08:34 (AEST)

Latest Articles

Paradigm unlocks $40M loan – and sees a 75cps price not far away

Paradigm Biopharmaceuticals (ASX:PAR) shares were up nearly +25% in morning trades as the company unveiled a loan of around $41 million to advance its osteoarthritis clinical investigations.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from thr...

Paradigm adds new oral combo IP to osteoarthritis drug stable with $500K pick-up

Paradigm Biopharmaceuticals (ASX:PAR) has acquired the exclusive global rights to develop @ and, of course, commercialise @ a novel oral combination of PPS and a COX-2 inhibitor designed to treat osteoarthritis and pains.Listen to the HotCopper podcast for in-depth discussions and insights on all...

Paradigm activates first Aus site for osteoarthritis drug trials

Paradigm Biopharmaceuticals Ltd has opened its first Australian site as part of a trial to assess injectable pentosan polysulfate sodium

Buyers (Bids)

Sellers (Offers)

Top Stories

Featured News